147
•
Caballero B (2007). The global epidemic of obesity: an overview. Epidemiol Rev
29, 1-5.
•
Calvo-Monfil C (2005) Dislipemias y atherosclerosis. En: Bioquímica y
Fisiopatología de la Nutrición (eds M Cascales, D Espinós y P García Barreno). Instituto de
España Madrid pp 257-276
•
Canale MP, Manca di Villahermosa S, Martino G Rovella V, Noce A, De Lorenzo
A y Di Daniele N (2013) Obesity-Related Metabolic Syndrome: Mechanisms of
sympathetic overactivity. Intern J Endocrinol 2013, Article ID 865965, 12 áginas
•
Cascio G, Schiera G, Di Liegro I (2012) Dietary fatty acids in metabolic syndrome,
diabetes and cardiovascular diseases. Curr Diabetes Rev 8, 2-17.
•
De Luca C y Olefsky JM (2009) Inflammation and insulin resistance. FEBS 582,
97-105.
•
Després JP, Lemieux I, Bergeron J et al., (2008) Abdominal Obesity and the
Metabolic Syndrome: contribution to global cardiometabolic risk. Arteriosclerosis,
Thrombosis, and Vascular Biology, 28, 1039–1049,.
•
Fernandez-Veledo,S, Nieto-Vazquez,I, et al., (2008) Hyperinsulinemia induces
insulin resistance on glucose and lipid metabolism in a human adipocytic cell line:
paracrine interaction with myocytes. J Clin Endocrinol Metab 93, 2866-2876.
•
Fuentes E, Guzmán-Jofre L, Moore-Carrasco R y Palomo I (2013) Role of PPARs
in inflammatory processes associated with metabolic syndrome (Review) Mol Med Reports
8, 1611-1616.
•
Nieto-Vazquez,I, Fernandez-Veledo,S, de Alvaro,C, Lorenzo,M (2008) Dual role of
interleukin-6 in regulating insulin sensitivity in murine skeletal muscle. Diabetes 57:3211-
3221, 2008
•
Fernandez-Veledo,S, Nieto-Vazquez,I, Vila-Bedmar,R, Garcia-Guerra,L, Alonso-
Chamorro,M, Lorenzo,M (2009) Molecular mechanisms involved in obesity-associated
insulin resistance: therapeutical approach. Arch Physiol Biochem 115, 227-239.
•
Fernandez-Veledo,S, Vila-Bedmar,R, Nieto-Vazquez,I, Lorenzo,M (2009) c-Jun N-
terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in
human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists. J
Clin Endocrinol Metab 94:3583-3593.
